Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
DTECTIO logo — AI powered Digital biomarkers platform to democratize access...

DTECTIO

AI powered Digital biomarkers platform to democratize access to preventive and personalized medicine.

Founded 2021 2 employees

General Information

Company Name DTECTIO
Founded Year 2021
Employees 2
Social

Get notified when DTECTIO moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About DTECTIO

DTECTIO is a startup that aims to revolutionize access to preventive and personalized medicine through its AI-powered Digital Biomarkers platform. By leveraging everyday connected devices, the platform continuously and non-invasively collects patient data, converting it into digital biomarkers. This innovative approach enables the early detection of silent pathologies and bioclinical anomalies, as well as the monitoring of disease progression and treatment effectiveness – all at affordable costs. Founded in 2021, DTECTIO's vision is to democratize access to preventive and personalized medicine, marking a significant advancement in the healthcare industry. With its potential to transform healthcare monitoring and diagnosis, DTECTIO presents an exciting opportunity for venture capital investors seeking to support cutting-edge innovations in the medical field.

Taxonomy: Digital biomarkers, Preventive medicine, Personalized medicine, Health tech, IoT devices, Continuous patient monitoring, Non-invasive healthcare technology, Early disease detection, Health data analytics, Healthcare innovation, Patient-centered care, Medical technology, Remote patient monitoring, AI-powered healthcare

No funding data available for DTECTIO yet.

Get notified when DTECTIO raises funding

FAQ About DTECTIO

AI powered Digital biomarkers platform to democratize access to preventive and personalized medicine.
DTECTIO was founded in 2021.
DTECTIO has approximately 2 employees.

We're actively collecting intelligence on DTECTIO.

Track DTECTIO to get notified

Don't just browse. Track.

Signal Tracker monitors DTECTIO and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes